Eurofins Genomics US SARS-CoV-2 Plasmid DNA Controls

Apr 16, 2020

Eurofins Genomics US and its subsidiary BlueHeron Biotechnology have launched three SARS-CoV-2 plasmid DNA controls for verifying the presence of the virus. The controls are intended for use in both R&D and diagnostic applications and target key segments in the virus genome. One of them, CVGP, covers a large part of the viral sequence.